Unlocking the potential of retinoic acid in anticancer therapy

por Schenk, T, Stengel, S, Zelent, A
Publicado 2014

Muscle-building supplement use and increased risk of testicular germ cell cancer in men from Connecticut and Massachusetts

por Li, N, Hauser, R, Holford, T, Zhu, Y, Zhang, Y, Bassig, B A, Honig, S, Chen, C, Boyle, P, Dai, M, Schwartz, S M, Morey, P, Sayward, H, Hu, Z, Shen, H, Gomery, P, Zheng, T
Publicado 2015

Occupational exposure to endocrine disruptors and lymphoma risk in a multi-centric European study

por Costas, L, Infante-Rivard, C, Zock, J-P, Van Tongeren, M, Boffetta, P, Cusson, A, Robles, C, Casabonne, D, Benavente, Y, Becker, N, Brennan, P, Foretova, L, Maynadié, M, Staines, A, Nieters, A, Cocco, P, de Sanjosé, S
Publicado 2015

A differentiated approach to referrals from general practice to support early cancer diagnosis – the Danish three-legged strategy

por Vedsted, P, Olesen, F
Publicado 2015

Monitoring gastric cancer progression with circulating tumour DNA

por Hamakawa, T, Kukita, Y, Kurokawa, Y, Miyazaki, Y, Takahashi, T, Yamasaki, M, Miyata, H, Nakajima, K, Taniguchi, K, Takiguchi, S, Mori, M, Doki, Y, Kato, K
Publicado 2015

Imaging tumour hypoxia with positron emission tomography

por Fleming, I N, Manavaki, R, Blower, P J, West, C, Williams, K J, Harris, A L, Domarkas, J, Lord, S, Baldry, C, Gilbert, F J
Publicado 2015

Comparing comparators: a look at control arms in kidney cancer studies over the years

por Bracarda, S, Porta, C, Sisani, M, Marrocolo, F, Paglino, C, Hamzaj, A, D Buono, S, Sternberg, C N
Publicado 2015

Physical function as a prognostic biomarker among cancer survivors

por Brown, J C, Harhay, M O, Harhay, M N
Publicado 2015

Epigenetics in acute promyelocytic leukaemia pathogenesis and treatment response: A TRAnsition to targeted therapies

por Arteaga, M F, Mikesch, J-H, Fung, T-K, So, C W E
Publicado 2015

Diet, exercise, obesity, smoking and alcohol consumption in cancer survivors and the general population: a comparative study of 16 282 individuals

por Wang, Z, McLoone, P, Morrison, D S
Publicado 2015

Enthusiasm for cancer screening in Great Britain: a general population survey

por Waller, J, Osborne, K, Wardle, J
Publicado 2015

Anti-programmed cell death protein-1/ligand-1 therapy in different cancers

por Homet Moreno, B, Ribas, A
Publicado 2015

Age-specific risk of breast cancer in women with neurofibromatosis type 1

por Seminog, O O, Goldacre, M J
Publicado 2015

Guidelines for the use of cell lines in biomedical research

por Geraghty, R J, Capes-Davis, A, Davis, J M, Downward, J, Freshney, R I, Knezevic, I, Lovell-Badge, R, Masters, J R W, Meredith, J, Stacey, G N, Thraves, P, Vias, M
Publicado 2014

Hitting the brakes: targeting microtubule motors in cancer

por Chandrasekaran, Gayathri, Tátrai, Péter, Gergely, Fanni
Publicado 2015

MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients

por Pichler, M, Calin, G A
Publicado 2015

Risk prediction tools for cancer in primary care

por Usher-Smith, Juliet, Emery, Jon, Hamilton, Willie, Griffin, Simon J, Walter, Fiona M
Publicado 2015

Chetomin, targeting HIF-1α/p300 complex, exhibits antitumour activity in multiple myeloma

por Viziteu, Elena, Grandmougin, Camille, Goldschmidt, Hartmut, Seckinger, Anja, Hose, Dirk, Klein, Bernard, Moreaux, Jerome
Publicado 2016

Lung cancer risk at low radon exposure rates in German uranium miners

por Kreuzer, M, Fenske, N, Schnelzer, M, Walsh, L
Publicado 2015

Gene–environment interaction and risk of breast cancer

por Rudolph, Anja, Chang-Claude, Jenny, Schmidt, Marjanka K
Publicado 2016